首页|期刊导航|药物分析学报（英文）|Prediction of fibril formation by early-stage amyloid peptide aggregation

Prediction of fibril formation by early-stage amyloid peptide aggregation

Jiaojiao Hu Huiyong Sun Haiping Hao Qiuling Zheng

药物分析学报（英文）2020，Vol.10Issue(2)：194-199,6.

Prediction of fibril formation by early-stage amyloid peptide aggregation

Jiaojiao Hu ¹Huiyong Sun ²Haiping Hao ³Qiuling Zheng²

作者信息

1. Department of Pharmaceutical Analysis,School of Pharmacy,China Pharmaceutical University,Tongjiaxiang #24,Nanjing,Jiangsu,210009,China
2. State Key Laboratory of Natural Medicines,China Pharmaceutical University,Tongjiaxiang #24,Nanjing,Jiangsu,210009,China
3. Department of Medicinal Chemistry,School of Pharmacy,China Pharmaceutical University,Tongjiaxiang #24,Nanjing,Jiangsu,210009,China
折叠

摘要

关键词

Mass spectrometry/Amyloid fibril/Early-stage oligomer/Peptide aggregation

Key words

Mass spectrometry/Amyloid fibril/Early-stage oligomer/Peptide aggregation

引用本文复制引用

Jiaojiao Hu,Huiyong Sun,Haiping Hao,Qiuling Zheng..Prediction of fibril formation by early-stage amyloid peptide aggregation[J].药物分析学报（英文）,2020,10(2):194-199,6.

基金项目

This work was supported by National Natural Science Founda-tion of China (Grant Nos. 81930109, 81720108032, 81430091, 81421005, 81703471, and 81603031), the Natural Science Founda-tion of Jiangsu Province (Grant No. BK20170740), the 111 project (Grant No. G20582017001), projects for Major New Drug Innova-tion and Development (Grant Nos. 2018ZX09711001-002-003 and 2018ZX09711002-001-004), the State Key Laboratory of Natural Medicines at China Pharmaceutical University, China (Grant No. SKLNMZZCX201817), and a"Double-First Rate"project (Grant No. CPU2018GF09). （Grant Nos. 81930109, 81720108032, 81430091, 81421005, 81703471, and 81603031）

药物分析学报（英文）

OASCI

ISSN：2095-1779

访问量0

下载量0

段落导航